CTCX logo

Carmell Therapeutics (CTCX)

Profile

Full Name

Longevity Health Holdings, Inc.

Ticker Symbol

CTCX

Exchange

NASDAQ

Sector

Consumer Defensive

Industry

Household & Personal Products

Country

United States

IPO

September 23, 2021

Indexes

Not included

Website

http://www.carmellcosmetics.com

Employees

9

Key Details

Price

$0.12(-3.11%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$50.32K

Annual EPS

-

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.12
CTCX price is $0.12

30-Day Relative Volume

0.04
CTCX 30-day relative volume is 0.04

Price Performance

Price Most recent change

-3.11%
CTCX price was down -3.11% on Apr 11, 2025

Price YTD change

-55.34%
CTCX price is down -55.34% since January 1st

Price 1-year change

-95.15%
CTCX price is down -95.15% year-on-year

Price 3-year change

-98.72%
CTCX price is down -98.72% over the past 3 years

Price Range

Price All-time high

$13.31
CTCX price is currently -99.06% below its historical high of $13.31

Price 3-year low

$0.10
CTCX price is currently +24.60% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.60M
CTCX market capitalization is $2.60 million

Market cap 3-year change

-
CTCX market capitalization 3-year change is unknown

Market cap All-time high

$187.36M
CTCX market capitalization is currently -98.61% below its historical high of $187.36 million

Market cap sector rank

6.4%
CTCX market capitalization is higher than 6.4% of companies in Consumer Defensive sector

Shares Outstanding

Shares Outstanding 1-Year Change

+7.98%
CTCX shares outstanding is up +7.98% year-on-year

Shares Outstanding 3-Year Change

-
CTCX shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.45
CTCX beta is 0.45

200-day SMA

$0.51
CTCX price is currently -75.75% below its 200-day simple moving average

50-day SMA

$0.22
CTCX price is currently -43.23% below its 50-day simple moving average

RSI

34.23
CTCX 14-day relative strength index is 34.23

Volume

0.04
CTCX 30-day relative volume is 0.04

ATR

$0.03
CTCX average true range is $0.03

10-day Historical Volatility

88.22%
CTCX 10-day historical volatility is 88.22%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$50.32K
CTCX annual revenue is $50.32 thousand

Revenue Analysts estimate

-
CTCX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
CTCX annual revenue 1-year change is unknown

Revenue Sector rank

0.8%
CTCX annual revenue is higher than 0.8% of companies in Consumer Defensive sector

EPS

EPS

-
CTCX annual earnings per share value is unknown

EPS Analysts estimate

-
CTCX annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-
CTCX annual earnings per share 1-year change is unknown

EPS Sector rank

-
CTCX annual earnings per share is unknown

Profit

Gross profit

$43.96K
CTCX annual gross profit is $43.96 thousand

Gross margin

87.37%
CTCX annual gross profit margin is 87.37%

Operating profit

-$5.00M
CTCX annual operating income is -$5.00 million

Operating margin

-9933.82%
CTCX annual operating profit margin is -9933.82%

Net income

-$10.37M
CTCX annual net profit is -$10.37 million

Net margin

-
CTCX annual net profit margin value is unknown

Expenses

Total expenses

$5.05M
CTCX annual total expenses is $5.05 million

Operating expenses

$5.04M
CTCX annual total operating expenses is $5.04 million

Cost of goods sold

$6357.00
CTCX annual cost of goods sold is $6357.00

Selling, general & administrative expenses

$3.90M
CTCX annual SGA is $3.90 million

Depreciation and amortization

$197.26K
CTCX annual depreciation & amortization is $197.26 thousand

Interest expense

$49.02K
CTCX annual interest expense is $49.02 thousand

Income tax

-$97.28K
CTCX annual income tax is -$97.28 thousand

EBIT & EBITDA

EBIT

-$10.70M
CTCX annual earnings before interest & taxes is -$10.70 million

EBITDA

-$4.76M
CTCX annual EBITDA is -$4.76 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.47M
CTCX annual total assets is $1.47 million

Non current assets

$518.43K
CTCX annual long term assets is $518.43 thousand

Current assets

$955.55K
CTCX annual total current assets is $955.55 thousand

Cash and cash equivalents

$157.14K
CTCX annual cash & cash equivalents is $157.14 thousand

Accounts receivable

$4096.00
CTCX annual accounts receivable is $4096.00

Inventory

$108.70K
CTCX annual inventory is $108.70 thousand

Liabilities

Total liabilities

$6.19M
CTCX annual total liabilities is $6.19 million

Long term liabilities

$309.94K
CTCX annual total long term liabilities is $309.94 thousand

Current liabilities

$5.88M
CTCX annual total current liabilities is $5.88 million

Accounts payable

$4.06M
CTCX annual accounts payable is $4.06 million

Debt

Total debt

$638.99K
CTCX annual total debt is $638.99 thousand

Total debt 1-year change

-70.09%
CTCX annual total debt is down -70.09% year-on-year

Long term debt

$309.94K
CTCX annual long term debt is $309.94 thousand

Short term debt

$241.16K
CTCX annual short term debt is $241.16 thousand

Equity & Capital

Shareholders equity

-$4.71M
CTCX annual stockholders equity is -$4.71 million

Book value

-$4.73M
CTCX annual book value is -$4.73 million

Retained earnings

-$68.87M
CTCX annual retained earnings is -$68.87 million

Working capital

-$4.92M
CTCX annual working capital is -$4.92 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$4.39M
CTCX annual cash flow from operations is -$4.39 million

Cash from operations 1-year change

+47.43%
CTCX annual cash flow from operations is up +47.43% year-on-year

Cash from investing

-$748.80K
CTCX annual cash flow from investing activities is -$748.80 thousand

Cash from investing 1-year change

-2355.07%
CTCX annual cash flow from investing activities is down -2355.07% year-on-year

Cash from financing

$2.38M
CTCX annual cash flow from financing activities is $2.38 million

Cash from financing 1-year change

-78.66%
CTCX annual cash flow from financing activities is down -78.66% year-on-year

CAPEX

CAPEX

-
CTCX annual capital expenditures value is unknown

CAPEX 1-year change

-
CTCX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$4.39M
CTCX annual free cash flow is -$4.39 million

Free cash flow 1-year change

+47.62%
CTCX annual free cash flow is up +47.62% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

87.37%
CTCX annual gross profit margin is 87.37%

Operating margin

-9933.82%
CTCX annual operating profit margin is -9933.82%

Net margin

-
CTCX annual net profit margin value is unknown

ROA & ROE

ROA

-703.42%
CTCX annual return on assets is -703.42%

ROE

220.01%
CTCX annual return on equity is 220.01%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CTCX price to earnings ratio value is unknown

PE ratio Sector rank

-
CTCX price to earnings ratio is unknown

PB Ratio

PB ratio

-0.55
CTCX price to book ratio is -0.55

PB ratio Sector rank

5.26%
CTCX price to book ratio is higher than 5.26% of companies in Consumer Defensive sector

PS Ratio

PS ratio

51.81
CTCX price to sales ratio is 51.81

PS ratio Sector rank

99.08%
CTCX price to sales ratio is higher than 99.08% of companies in Consumer Defensive sector

Enterprise value

Enterprise value

$3.09M
CTCX enterprise value is $3.09 million

Enterprise value Sector rank

4.07%
CTCX enterprise value is higher than 4.07% of companies in Consumer Defensive sector

EV/EBITDA

EV/EBITDA

-0.29
CTCX EV/EBITDA is -0.29

EV/EBITDA Sector rank

26.27%
CTCX EV/EBITDA is higher than 26.27% of companies in Consumer Defensive sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.16
CTCX annual current ratio is 0.16

Quick ratio

0.14
CTCX annual quick ratio is 0.14

Leverage

Debt to equity

-0.14
CTCX annual debt to equity ratio is -0.14

Interest coverage ratio

-218.27
CTCX annual interest coverage ratio is -218.27

Risk & Stability

Piotroski F-Score

-
CTCX piotroski f-score value is unknown

Altman Z-Score

-93.09
CTCX altman z-score is -93.09

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

STKH logo
Steakholder Foods (STKH)
AQB logo
AquaBounty Technologies (AQB)
AGRI logo
AgriFORCE Growing Systems (AGRI)
Heritage Distilling Holding (CASK)
EDBL logo
Edible Garden AG Incorporated (EDBL)
TANH logo
Tantech Holdings Ltd (TANH)
GNLN logo
Greenlane Holdings (GNLN)
CYAN logo
Cyanotech (CYAN)
SBEV logo
Splash Beverage (SBEV)
  • What is the ticker symbol for Carmell Therapeutics?
  • Does Carmell Therapeutics pay dividends?
  • What sector is Carmell Therapeutics in?
  • What industry is Carmell Therapeutics in?
  • What country is Carmell Therapeutics based in?
  • When did Carmell Therapeutics go public?
  • Is Carmell Therapeutics in the S&P 500?
  • Is Carmell Therapeutics in the NASDAQ 100?
  • Is Carmell Therapeutics in the Dow Jones?
  • When was Carmell Therapeutics's last earnings report?
  • When does Carmell Therapeutics report earnings?

What is the ticker symbol for Carmell Therapeutics?

The ticker symbol for Carmell Therapeutics is NASDAQ:CTCX

Does Carmell Therapeutics pay dividends?

No, Carmell Therapeutics does not pay dividends

What sector is Carmell Therapeutics in?

Carmell Therapeutics is in the Consumer Defensive sector

What industry is Carmell Therapeutics in?

Carmell Therapeutics is in the Household & Personal Products industry

What country is Carmell Therapeutics based in?

Carmell Therapeutics is headquartered in United States

When did Carmell Therapeutics go public?

Carmell Therapeutics's initial public offering (IPO) was on September 23, 2021

Is Carmell Therapeutics in the S&P 500?

No, Carmell Therapeutics is not included in the S&P 500 index

Is Carmell Therapeutics in the NASDAQ 100?

No, Carmell Therapeutics is not included in the NASDAQ 100 index

Is Carmell Therapeutics in the Dow Jones?

No, Carmell Therapeutics is not included in the Dow Jones index

When was Carmell Therapeutics's last earnings report?

Carmell Therapeutics's most recent earnings report was on Nov 14, 2024

When does Carmell Therapeutics report earnings?

The next expected earnings date for Carmell Therapeutics is May 15, 2025
On this page